CYCLIC TETRAPEPTIDE STEREOISOMERS
    1.
    发明申请

    公开(公告)号:US20190241612A1

    公开(公告)日:2019-08-08

    申请号:US16383016

    申请日:2019-04-12

    CPC classification number: C07K5/126 A61K38/00 C07K5/12

    Abstract: Cyclic tetrapeptide stereochemical isomers of CJ-15,208, pharmaceutical compositions from such cyclic tetrapeptides, and methods of using such pharmaceutical compositions. The cyclic tetrapeptide compounds and pharmaceutical compositions disclosed herein are potent analgesics active in several pain models with generally minimal tolerance and reduced likelihood to induce addiction relative to other known opiates.

    CYCLIC TETRAPEPTIDE STEREOISOMERS
    2.
    发明申请

    公开(公告)号:US20170190738A1

    公开(公告)日:2017-07-06

    申请号:US15325177

    申请日:2015-07-13

    CPC classification number: C07K5/126 A61K38/00 C07K5/12

    Abstract: Cyclic tetrapeptide stereochemical isomers of CJ-15,208, pharmaceutical compositions from such cyclic tetrapeptides, and methods of using such pharmaceutical compositions. The cyclic tetrapeptide compounds and pharmaceutical compositions disclosed herein are potent analgesics active in several pain models with generally minimal tolerance and reduced likelihood to induce addiction relative to other known opiates.

    Cyclic tetrapeptide stereoisomers

    公开(公告)号:US10259843B2

    公开(公告)日:2019-04-16

    申请号:US15325177

    申请日:2015-07-13

    Abstract: Cyclic tetrapeptide stereochemical isomers of CJ-15,208, pharmaceutical compositions from such cyclic tetrapeptides, and methods of using such pharmaceutical compositions. The cyclic tetrapeptide compounds and pharmaceutical compositions disclosed herein are potent analgesics active in several pain models with generally minimal tolerance and reduced likelihood to induce addiction relative to other known opiates.

    Cyclic tetrapeptide stereoisomers

    公开(公告)号:US10988506B2

    公开(公告)日:2021-04-27

    申请号:US16383016

    申请日:2019-04-12

    Abstract: Cyclic tetrapeptide stereochemical isomers of CJ-15,208, pharmaceutical compositions from such cyclic tetrapeptides, and methods of using such pharmaceutical compositions. The cyclic tetrapeptide compounds and pharmaceutical compositions disclosed herein are potent analgesics active in several pain models with generally minimal tolerance and reduced likelihood to induce addiction relative to other known opiates.

Patent Agency Ranking